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 Abstract 
Histone lysine methylation is considered to be a relatively stable modification 
associated with important functions in epigenetic gene control and for organizing 
chromatin domains. Genes encoding mammalian homologues of the Drosophila 
suppressor of PEV Su(var)3-9 were the first shown to encode proteins with histone 
lysine methyl-transferase (HKMT) activity. A hallmark signature of this class of 
proteins is the evolutionary conserved SET-domain found in numerous chromatin 
regulators, and was named for its occurrence in genes encoding three such regulators 
in Drosophila, namely Su(var)3-9, E(z) and trithorax.  
Here we describe the characterization of a putative SET-domain gene in Drosophila 
melanogaster, G9a. The gene encodes a protein of 1637 amino acids with similar 
domain architecture as the mammalian homologue of same name. Whole mount in 
situ hybridization shows that the gene is maternal and immunostaining shows nuclear 
localization of DmG9a. A yeast two-hybrid screening revealed that DmG9a interacts 
with Tungus, a LIM-domain protein associated with α-Actinin. Further analysis is 
needed to investigate the functional implications of this putative interaction.
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1. Introduction 
1.1 Chromatin and SET-domain proteins 
1.1.1 Packaging of DNA 
Eukaryotic cells contain considerable amounts of DNA that has to fit into the 
nucleus. To accomplish this, nucleotides are tightly folded into a complex called 
chromatin with the help of specialized proteins called histones that provide 
increasingly higher levels of organization (Fig. 1.1). 
 
Figure 1.1: Multiple levels of chromatin folding. The basic repeated unit of chromatin is the nucleosome. 
The nucleosomes are arranged in a “beads on a string” fashion. These are again packaged into a structure 
called 30nm fiber. Chromatin structure beyond this stage remains uncharacterized. Adapted from Horn and 
Peterson (2002). 
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The basic repeated unit of chromatin is the nucleosome. It is composed of a helix of 
147 bp DNA wrapped 1.7 times around an octamer of core histones (Luger et al. 
1997). Each core nucleosome is composed of two dimers of H2A and H2B and one 
tetramer of H3-H4. Linker histone, H1, associate with 10-60 bp of DNA between 
single nucleosomes establishing an increased level of organization, the 30 nm fiber. 
Conformation beyond this structure is less characterized, and the grade of compaction 
varies. It is either in a highly compact state called heterochromatin, or in a less tightly 
packed state called euchromatin. The more closed state of heterochromatin contains 
few actively expressed genes, whereas euchromatin is associated with active 
transcription. Chromatin is a highly flexible structure which undergoes dynamic 
changes during many genetic processes. They include necessary structural 
reorganizations that occur during DNA replication and cell cycle progression, 
spatially and temporally coordinated gene expression, as well as DNA repair and 
recombination events.  
Heterochromatin is further differentiated into a constitutive and a facultative state. 
Constitutive heterochromatin is permanently condensed and is predominantly found 
at centromeric and telomeric chromosomal regions, as well as in regions containing 
transposable elements. In contrast, facultative heterochromatin represents transiently 
condensed and silenced euchromatin. Best known examples are the inactivated X 
chromosome in female mammals, and position-effect variegation (PEV). PEV as a 
phenomenon was first described in Drosophila melanogaster (Muller 1930) where 
euchromatic genes in the vicinity of heterochromatic sequences can be become 
transcriptionally silent due to chromosomal rearrangement or transposition. The 
extent of silencing varies from one clonal population to another and thus gives rice to 
the variegated phenotypes. The finding of PEV did not only support the link between 
heterochromatin and transcriptional silencing, but also suggested that there exist 
changes that influence phenotype without altering DNA sequence. The study of 
stable alterations in gene expression potential that not are mediated at the DNA 
sequence level is called epigenetics, and includes post-synthetic modifications on 
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either DNA itself or of proteins that intimately associate with DNA as the key 
mediators. 
1.1.2 Histone code hypothesis 
The N-terminal histone tails are extending outwards from the core of the nucleosomes 
(Fig. 1.2), and are highly accessible for covalent post-translational modifications such 
as acetylation, phosphorylation, methylation, ADP-ribosylation and ubiquitination 
(Ausio et al. 2001). The first three modifications have been studied extensively in the 
resent years; however, further studies are needed in order to elucidate the complete 
function of all these modifications (Margueron et al. 2005). Enzymes transferring 
these characterized modifications are highly specific for particular amino acid 
positions. They may contribute to an alteration in the interaction of the histone tails 
with DNA or with chromatin-associated proteins that may be required for different 
downstream cellular processes. Several years of work on histone modifications and 
regulation of gene expression lead to the “histone code” hypothesis (Strahl and Allis 
2000; Turner 2002). This model postulates that the modifications in different 
variations specify a language that dictates the regulatory features of a gene, and is 
read by a set of proteins that translate the code into a particular chromatin state, either 
active or repressed. It is, however, important to realize that the pattern of histone 
marks can be differentially interpreted by cellular factors, depending on the gene 
being studied and the cellular context (Peterson and Laniel 2004).  
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Figure 1.2: Histone modifications on the nucleosome core particle.  Illustration of how the histone tails 
protrude out of the nucleosome core particle. Colored symbols indicate sites of post-translational modifications 
that are defined at the lower left; acK, acetyl lysine; meR, methyl arginine; meK, methyl lysine; PS, phosphoryl 
serine; uK, ubiquitinated lysine. Numbers indicate residue for each modification. Notice that H3-K9 can be 
both methylated and acetylated (Figure adapted from Turner (2002) 
1.1.3 Histone modifications  
One of the best understood modifications is acetylation, which in general is linked to 
transcriptional activation because histone acetylation decreases inter-nucleosome 
interaction and interaction of histone tails with linker DNA, thereby allowing greater 
accessibility (Khorasanizadeh 2004). The acetyl group can be removed by 
deacetylases which functions as repressors, thus, the combined actions of these 
enzymes serve as a rapid mean of switch between active and repressive states 
(Vermaak et al. 2003). 
Although all histones are phosphorylated in vivo, the function of many of these 
modifications and the kinases that carry them out are not known (Isenberg 1979). 
Over the resent years some progress has been done in understanding what functions 
this mark can have on transcriptional regulation; phosphorylation of histone H2B at 
serine 14 (S14) in vertebrates is associated with apoptotic chromatin, whereas in all 
eukaryotes phosphorylation of histone H3-S10 is associated with transcriptionally 
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active and mitotic chromatin (Goll and Bestor 2002; Cheung et al. 2003; Fischle et al. 
2003).  
Histone methylation is catalyzed by histone methyl-transferases (HMTs), but it does 
not change the overall charge of the nucleosome. HMTs can be grouped into two 
families: protein arginine methyl-transferases (PRMTs) and histone lysine methyl-
transferases (HKMTs). Two types of PRMTs transfer methyl groups to protein 
substrates; Type I PRMT enzymes form mono-methyl-arginine and asymmetric di-
methyl-arginine products, while Type II PRMT enzymes catalyze the formation of 
mono-methyl-arginine and symmetric di-methyl-arginine (Gary and Clarke 1998; 
McBride and Silver 2001). Methylation of specific arginines on histones H3 and H4 
correlate with the active state of transcription (Lee et al. 2005). 
Histone lysine methylation has been considered to be a long-term epigenetic mark of 
maintaining chromatin states due to the fact that no demethylase had been identified 
(Jenuwein and Allis 2001). However, other mechanisms than enzymatic activity had 
been proposed for removal of1u histones methylated on lysines from the nucleosome 
(Jenuwein and Allis 2001; Ahmad and Henikoff 2002; Bannister et al. 2002). The 
resent identification of a histone lysine demethylase has therefore provided some 
surprise (Kubicek and Jenuwein 2004; Shi et al. 2004). This discovery, in addition to 
the putative revelation of other demethylases will not, however, necessarily change 
the notion that histone lysine methylation has a role in epigenetic regulation of genes 
(Kubicek and Jenuwein 2004). 
1.1.4 SET-domain proteins 
Genes encoding mammalian homologues of the Drosophila suppressor of PEV 
Su(var)3-9 were the first to be shown to encode proteins with HKMT activity (Rea et 
al. 2000). A hallmark signature of this class of HKMTs is the presence of the 130-
amino acid SET-domain, which is crucial for catalytic activity but also requires 
adjacent cysteine-rich domains (Rea et al. 2000). The evolutionary conserved SET-
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domain found in numerous chromatin regulators, was named for its occurrence in 
genes encoding three such regulators in Drosophila, namely Su(var), E(z) and 
trithorax (Jenuwein et al. 1998). Many SET-domain proteins have been shown to 
possess HKMT activity towards specific lysine residues on histone tails, leading to 
positive or negative regulation of gene expression (Kouzarides 2002; Lachner and 
Jenuwein 2002). Substrate specificity of SET-domain HKMTs is thought to be 
modulated through combination with the two flanking cystein-rich motifs called 
PRE-SET and POST-SET (Lachner and Jenuwein 2002). Methylated lysines are 
identified by proteins containing chromodomains, which were first identified in two 
regulators of chromatin structure in Drosophila: heterochromatin protein 1 (HP1) and 
Polycomb (Paro and Hogness 1991). So far, SET-containing HKMTs that methylate 
K4, K9, K27 and K36 of histone H3 and K20 of histone H4 have been identified 
(Cheng et al. 2005). Currently, all but one of the known histone residues that are 
methylated (H3-K79) are modified by SET-domain proteins (Feng et al. 2002; Min et 
al. 2003). The HKMTs have been reported to mono-, di- and trimethylate lysine 
residues, leading to a possible increased level of complexity in the interpretation of 
the histone code (Dutnall 2003).  
73 entries have been found in the human genome which possess a SET-domain, 6 in 
Saccharomyces cerevisiae, 11 in Schizosaccharomyces pombe, 41 in Drosophila and 
37 in Caenorhabditis elegans (Kouzarides 2002). By alignment of the SET-domains 
of these proteins, they have been classified into four subgroups; E(Z), TRX, ASH1 
and SU(VAR)3-9 (Jenuwein et al. 1998).  
The best characterized methylation sites are lysines 9 and 27 on histone H3; the first 
is associated with heterochromatin-mediated silencing (Jacobs et al. 2001) and the 
other with epigenetic repression (Cao et al. 2002). H4-K20 methylation has also been 
shown to be associated with silent chromatin and prevents acetylation on H4-K16, a 
mark for active chromatin in humans (Cao et al. 2002). Transcriptionally competent 
euchromatin, however, is in general methylated at three positions; H3-K4, H3-K36 
and H3-K79 (Sims et al. 2003). 
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1.1.5 The SU(VAR)3-9 family 
SUV39H1 and Suv39h1 was the first HKMT identified in human and mouse, 
respectively, showing specific activity towards H3-K9 (Rea et al. 2000). These 
proteins are enriched in heterochromatin (Aagaard et al. 1999) and accumulate 
transiently at centromeric positions during mitosis (Aagaard et al. 2000). The 
homologue SU(VAR)3-9 has been shown to be the main HKMT specific for H3-K9 
in Drosophila. The methylation of H3-K9 is, however, influenced by pre-existing 
H3-S10 phosophorylation and H3-K9 acetylation, the first associated with 
chromosome condensation or segregation, the other with histone deposition (Strahl 
and Allis 2000). On the other hand, methylation of H3-K9 interferes with 
phosphorylation of H3-S10 that is dependent on the kinase Ipl1/aurora (Rea et al. 
2000). An interaction between SU(VAR)3-9 and the histone deacteylase HDAC1 in 
vivo has also been reported in Drosophila (Czermin et al. 2001), possibly leading to 
the generation of a more permanently repressed chromatin structure within an 
otherwise more accessible, acetylated chromatin (Czermin et al. 2001).  
Methylated H3-K9 creates a specific binding site for HP1 (Bannister et al. 2001; 
Jacobs et al. 2001; Lachner et al. 2001; Schotta et al. 2002). These observations have 
provided new insights into the mechanism of heterochromatin formation and 
maintenance. After primary association of SU(VAR)3-9 with heterochromatin, 
consecutive H3-K9 methylation will create binding sites for HP1 through its 
chromodomain (Bannister et al. 2001; Lachner et al. 2001). This will finally result in 
stable association of SU(VAR)3-9/HP1 complexes with heterochromatin and 
providing a feed-back loop for the methylation of adjacent nucleosomes (Jenuwein 
2001). This has also been supported by observations in Drosophila (Schotta et al. 
2002).  
Another well characterized member of the SU(VAR)3-9 family is the mammalian 
G9a. This protein shows specific selectivity to H3-K9, but in addition it is capable of 
methylating K27 on the same histone (Tachibana et al. 2001). It is essential for 
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embryonic development in mouse, and it is thought to be involved in transcriptional 
silencing of developmentally regulated genes in euchromatic regions (Tachibana et 
al. 2002).  
1.2 Drosophila melanogaster as a model organism 
Drosophila melanogaster provides an excellent model system in which to study 
genetics and development, in addition to epigenetics. Thomas Hunt Morgan became 
interested in heredity in the beginning of the 20th century, after Gregor Mendel’s 
work on genetic linkage was rediscovered, and together with his colleagues he 
published “The Mechanism of Mendelian Heredity” (Morgan et al. 1915). This was 
based on their work with Drosophila melanogaster. The reasons why he chose this 
species as an experimental organism was that it is small, has a short life cycle, 
produces a øarge amount of progeny and is easy to maintain in the laboratory. 
Additional advantages in working with this species have been discovered as well; 
there is no meiotic recombination in males, making it relatively easy to track 
chromosomes through generations. Drosophila melanogaster has only four 
chromosomes, which can be directly visualized in the larval salivary glands as the 
giant polytene chromsomes, and have provided a valuable tool in mapping genes. 
Furthermore, the Drosophila exoskeleton shows a wealth of external features such as 
bristles, compound eyes and body color, which can be affected by mutations and 
directly identified by investigation using a stereomicroscope. This has made it 
possible to link genotypic changes to phenotypic traits. After being studied in the 
laboratory for almost 100 years, a considerable number of techniques have been 
developed that have given Drosophila its role as one of the most important model 
organisms for genetic analysis (Rubin and Lewis 2000).  
Model organisms are used for studying human diseases and improving our 
knowledge about life, without having to encounter many of the ethical issues 
following research on humans, or even mice. Even though flies and mammals 
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diverged around 700 million years ago, many of the relevant developmental 
processes are essentially conserved (Adams et al. 2000). Drosophila melanogaster 
has only around 15000 genes, and surprisingly many of these have clear homologues 
in humans (Friedman and Hughes 2001), including genes that underlie many genetic 
disorders, including cancer (Fortini et al. 2000). The possibility to perform large 
genetic screens in Drosophila, one of the most important hallmarks of the organism, 
provides an unbiased way to identify genes in a particular process and a great 
potential to dissect a specific gene function (St Johnston 2002). 
1.2.1 The life cycle of Drosophila melanogaster 
Drosophila belongs to the order of Diptera, two-winged insects, and the family 
Drosophilidae. It is a holometabolous insect, meaning that it has a pupal stage 
interposed between the larval and adult form. The fertilized egg is laid in nutritious 
food, and the embryonic development lasts for about one day, before it hatches as a 
larva. The larva passes through three stages, or instars, where it spends almost all its 
time eating and gaining size. After about 40 hours in the third instar stage it climbs to 
a dry and clean place where it molts into a pupae. Here it undergoes metamorphosis 
where a radical remodeling of the body takes place, developing into the adult fly, also 
called imago. The whole process from fertilization to the final hatching of the adult 
fly takes about 10 days at 25ºC (Fig. 1.3).  
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Figure 1.3: The life cycle of Drosophila melanogaster. The egg undergoes 1 day of embryogenesis, before it 
hatches into a larva. The first and second instars last for 1day each, before hatching into the last instar stage, 
which lasts for 2 days. The pupa goes through metamorphosis, and after 5 days the adult fly emerges. Image 
adapted from FlyMove (Weigmann et al. 2003). 
 
1.2.2 Embryonic development in Drosophila 
The embryonic development of Drosophila melanogaster lasts for one day, and has 
been subdivided into 17 stages (Campos-Ortega and Hartstein 1985). Embryogenesis 
starts with the cleavage during which the nucleus of the fertilized egg performs 13 
rapid divisions; this takes place at stages 1-4. The divisions are not, however, 
followed by cytokinesis, resulting in a multinucleate cell called a syncytial 
blastoderm. At stage 5 the cellularization process starts, in which the resulting nuclei 
become arranged in a single layer beneath the egg surface of the embryo, and cell 
membranes are formed around the nuclei. The embryo is now called a cellular 
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blastoderm. At stage 6 the gastrulation process starts, leading to the formation of the 
three germ layers; ectoderm, mesoderm and endoderm. The subsequent development 
with various cell movements (e.g. germ band extension) results in an embryo with 
morphologically distinct segments along the anteroposterior axis.  
1.2.3 The genetics of Drosophila embryonic development 
Up to the cellular blastoderm stage development depends largely on maternal 
mRNAs and proteins that accumulate in the egg before fertilization, facilitating rapid 
development. These maternal-effect genes form the morphogenic gradients that are 
required to define the anteroposterior and dorsoventral axes of the embryo. They are 
transcription factors that regulate the expression of the zygotic gap genes, which 
roughly subdivide the embryo along the anteroposterior axis. Another level of 
complexity is added by the pair-rule genes; which are regulated by gap genes and 
divide the embryo into pairs of segments. Segment polarity genes are further 
controlled by pair-rule genes, and set the axis of each segment. All these classes of 
genes are together called segmentation genes, and they provide a hierarchy of signals 
that regulates segment patterning in Drosophila (Lawrence 1992). 
During embryonic development the segmentation genes are responsible for the 
activation of homeotic genes, which determines the identity of the different body 
segments along the anteroposterior axis (McGinnis and Krumlauf 1992). When the 
expression of the segmentation genes ceases shortly after gastrulation, the correct 
expression of the homeotic genes becomes dependent on proteins encoded by the 
Polycomb-group (PcG) and the trithorax-group (trxG) genes. The PcG proteins keep 
homeotic genes repressed in cells where they need to be inactive, whereas the trxG 
proteins sustain expression of homeotic genes where their products are required 
(Orlando and Paro 1995; Pirrotta 1998). They regulate expression patterns at the 
chromatin level and provide a transcriptional memory mechanism (Simon and 
Tamkun 2002). The SET-domain proteins were initially identified as members of the 
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PcG and trxG families, implying that this group is involved in the regulation of early 
development of Drosophila. 
1.2.4 Oogenesis 
The early embryonic development is, as mentioned, supported by maternally 
deposited mRNAs and proteins into the unfertilized egg. Also, the main axes of the 
future fly body are defined before fertilization. These features are accomplished 
during oogenesis.  
Drosophila ovaries are organized into approximately 15 ovarioles, each representing 
an independent egg assembly line. The ovarioles are tubular structures that contain 
progressively maturing egg chambers (Fig. 1.4), and are tipped with germ-line and 
somatic stem cells in which the development of the egg chambers is initiated. This 
region is called the germarium, and here each germ-line cell divides asymmetrically 
giving rice to one cytoblast and one stem cell. The cytoblast undergoes four rounds of 
cell division without completing cytokinesis, generating a cyst of 16 interconnected 
germ cells. One of these cells becomes the oocyte, while the remaining cells become 
nurse cells. Surrounding the 16 germ-line cells is a monolayer of somatic follicle 
cells. The subsequent development is divided into 14 morphological distinct stages 
(Spradling 1993). As oogenesis proceeds, the nurse cell nuclei become highly 
polyploid, whereas the oocyte remains arrested in meiotic prophase and is 
transcriptionally quiescent. Nurse cells actively transcribe and transport mRNA into 
the oocyte during stages 1 through 8 of oogenesis. At stages 9 through 10A a 
dramatic increase in nurse cell transcription is seen, and at stage 10B the nurse cells 
empty their remaining cytoplasm into the oocyte (dumping). This process is driven by 
a myosin-based contraction, and is followed by a modified form of cell death. The 
inducers of apoptosis in germ-line cells are not yet identified, although many of the 
molecules that execute the cell death program are likely to be the same as for somatic 
cells (Buszczak and Cooley 2000).   
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Figure 1.4: Drosophila egg chambers develop within ovarioles.  Oogenesis proceeds in an assembly line 
manner through 14 morphological distinct stages. Figure adapted from Hudson and Cooley (2002). 
The follicle cells surrounding the oocyte contribute with a complex set of signals that 
helps determine the future axis of the fertilized embryo, in addition to synthesizing 
the proteins of the tough eggshell (chorion) covering the egg chamber during the later 
stages of oogenesis (Margaritis et al. 1980). 
1.2.5 Genetic tools for investigating gene function 
In the beginning of the 20th century Thomas Hunt Morgan and his coworkers 
performed breeding experiments in their fly room. In 1910 their work was rewarded 
by the discovery of a mutant male fly with white eyes. Since spontaneous mutations 
occur very rarely, scientists have developed better ways to generate mutants, such as 
X-rays, gamma rays and chemical mutagens like ethyl methane sulphonate (EMS). In 
the beginning most mutagenesis studies were designed to generate point mutations in 
general. Christiane Nüsslein-Volhart and Eric Wieschaus were the first to perform a 
large-scale screen that set out to saturate the genome for mutations that affect a 
particular process, namely embryonic development (Nusslein-Volhard and 
Wieschaus 1980).  
An additional way to generate mutations is by the use of transposable elements. The 
P-element was discovered in Drosophila as the causative agent of a genetic syndrome 
called hybrid dysgenesis (Engels 1983). The main advantage with P-elements is that 
they can be easily identified and mapped by sequencing (St Johnston 2002). 
However, the preferential insertion into 5´-noncoding regions makes it impossible to 
mutate every gene in the genome (Spradling et al. 1995). The Berkeley Drosophila 
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Genome Project supplied a large collection of P-element insertions to the 
Bloomington Drosophila stock center (Spradling et al. 1999), which are available for 
the public. P-elements also provide a popular tool for the creation of transgenic flies 
by P-element transformation, or for other purposes like enhancer-traps screens 
(Spradling et al. 1999). 
1.2.6 The GAL4/UAS expression system 
The GAL4/UAS system is one of the most elegant tools developed for targeted gene 
expression in Drosophila. It was developed by Brand and Perrimon (1993) and is 
based on the yeast transcriptional activator GAL4. This protein regulates the 
transcription of genes GAL10 and Gal1 in yeast by directly binding to four essential 
and related 17 bp sequences, called Upstream Activating Sequences (UAS) (Giniger 
et al. 1985). GAL4 expression is capable of stimulating transcription of any reporter 
gene under UAS control in Drosophila (Fischer et al. 1988), and the protein has no 
deleterious phenotypic effects, and does not activate native Drosophila genes. GAL4 
transcription can be driven by various Drosophila promoters, resulting in expression 
in different tissues and at different times. 
Several fly stocks have been developed, either with characterized Drosophila 
genomic enhancers or by enhancer detection techniques, where GAL4 is expressed in 
different patterns. Other stocks contain insertions with a polylinker located between 
four UAS sequences and a SV40 terminator. This polylinker makes it possible to 
ligate any gene or sequence you wish to express at a specific time or in a specific 
tissue (Fig. 1.5). The advantage of this system is that it is possible to generate fly 
strains with ectopic expression of the sequence at interest in different tissues or cell 
types. It also makes it possible to separate the target sequence from its transcriptional 
activator in two different strains where they have no effect, and only through a 
crossing between these two strains the target gene is turned on in the progeny, and it 
is possible to se a phenotypic effect (Brand and Perrimon 1993). 
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Figure 1.5: The GAL4-UAS expression system. The enhancer and target gene is brought together in the 
progeny by a single crossing. The expression of GAL4 is driven by a time and tissue specific enhancer, and 
regulates the expression of the gene of interest. Figure adapted from St Johnston (2002). 
1.3 The Yeast Two-Hybrid system 
The yeast two-hybrid (Y2H) system (Fig. 1.6) is a genetic method for identifying and 
analyzing protein-protein interactions. The principle of the assay was first published 
in 1989 (Fields and Song 1989), and has proven to be one of the most efficient 
techniques for finding new interactions (Fields and Song 1989; Frederickson 1998; 
Drees 1999). The method is based on the properties of the yeast GAL4 protein, which 
consists of separable domains responsible for DNA-binding and transcriptional 
activation respectively (Keegan et al. 1986). Plasmids encoding two-hybrid proteins 
are constructed and introduced into two different yeast strains of opposite mating 
type. One, pGBKT7 (BD Biosciences), consists of the GAL4 DNA binding (DNA-
BD) domain fused to the protein of interest, the bait, whose interaction partners it is 
searched for. The other, pGADT7-Rec (BD Biosciences), consist of the GAL4 
activation (DNA-AD) domain, fused to a cDNA library obtained form the 
species/tissue of interest. When the two yeast strains are mated, and a positive 
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interaction with the bait and a protein of the library occurs, this will lead to a 
transcriptional activation of four reporter genes; ADE2, HIS3, lacZ and MEL1. By 
streaking colonies on quadruple dropout medium (QDO) lacking these four reporter 
products, the appearance of false positives is reduced. This is termed a quadruple 
reporter system.  
 
Figure 1.6: The yeast two-hybrid system principle. The bait is cloned into the DNA-BD vector where it is 
expressed as a fusion to the DNA binding domain of the yeast GAL4 protein. A second gene or cDNA library 
is cloned into the AD vector, where it is expressed as a fusion the activation domain of the GAL4. When the 
fusion proteins interact, the DNA-BD and AD domains are brought into close proximity and can activate 
transcription of reporter genes. (Figure adapted from the BD Biosciences Y2H user manual). 
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1.4 Aim of this project 
This study is part of a larger project where the goal is to examine possible 
mechanisms of epigenetic regulation of transcription in Drosophila melanogaster and 
Arabidopsis thaliana. Although a considerably amount of work has been laid down in 
the investigation of the histone code hypothesis, it is a complex field of study, and 
much must still be accomplished. To get a better understanding of epigenetic 
regulation of transcription it is essential to characterize all genes that are involved in 
the process, in different organisms.   
The aim of this thesis was to take advantage of genetic tools available in order to 
perform functional analysis of one putative SET-domain gene in Drosophila. The 
main objectives have been to: 
- characterize the gene using bioinformatics tools 
- investigate the in vivo localization and function  
- identify putative interaction partners using the yeast two-hybrid system 
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2. Materials and methods 
2.1 Fly stocks 
 
2.1.1 Wild type 
DmS, 93  
2.1.2 Balancer stocks 
yw; Sp/CyO; D/TM3,Sb 
FM6,w 
w1118; If/Cyo 
yw; D/TM3,Sb 
yw; Sp/Cyo; Ki/TM3,Sb 
2.1.3 Stocks used for the P-element excision  
13414: y[1] P{y[+mDint2] w[BR.E.BR]=SUPor-P}CG2995[KG01242]  
(http://rail.bio.indiana.edu/.bin/fbidq.html?FBst0013414&resultlist=fbstock19356.data) 
Containing the element (P{SUPor-P}) inserted in the 5'-end of the gene DmG9a. 
mus309D2: w1118/yw; mus309D2/TM3,Sb and 
∆2-3, mus309D3: w1118/yw; Sp/CyO; ∆2-3,mus309D2/TM3,Sb  
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mus309D2 and mus309D3 are two different alleles of mutations of the gene IRBP 
which is involved in double-strand DNA break repair and P-element transposition  
∆2-3 is the transposase catalyzing the reaction. 
FM6,w 
2.1.4 Stocks used for the over expression assay 
#4414: y[1] w[*]; P{w[+mC]=Act5C-GAL4}25FO1/CyO, y[+] 
(http://flybase.bio.indiana.edu/.bin/fbidq.html?FBst0004414&resultlist=fbstock27650.data) 
GAL4 expression driven by the promoter of the ubiquitously expressed gene Act5c 
(http://flybase.bio.indiana.edu/.bin/fbidq.html?FBgn0000042) 
#5460: w[*]; P{w[+mW.hs]=GAL4-da.G32}UH1 
(http://flybase.bio.indiana.edu/.bin/fbidq.html?FBst0005460&resultlist=fbstock27960.data) 
GAL4 expression driven by the promoter of the ubiquitously expressed gene 
daughterless. ( http://flybase.bio.indiana.edu/.bin/fbidq.html?FBgn0000413) 
2.2 Genetics 
2.2.1 Over expression of the gene DmG9a 
In order to investigate the function of the gene DmG9a, a construct was made for 
over expression of the gene. A PCR reaction was run using the primers 
2995cDNAattB1 and cg2995Y2H4attB2, and pCRII-TOPO-DmG9a as template. The 
product of this reaction was Gateway cloned, via the vector pDONR/Zeo (Invitrogen 
Life Technologies), into the vector pPWF (http://www.ciwemb.edu/labs/murphy/ 
Gateway%20vectors.html). This vector contains a strong UAS promoter, and a copy of the 
mini-white gene, in addition to a Gateway cassette. The vector was injected into w1118 
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embryos (Ann Mari Voie) using P-element transformation. These transgenic flies 
were crossed to different balancer stocks in order to map what chromosome the 
insertion had happened. The resulting stocks were then crossed to #4414 or #5460 
flies. 
2.2.2 Promoter analysis 
The DmG9a promoter was cloned into the pCaSpeR-AUG-ßgal 
(http://flybase.bio.indiana.edu/.bin/fbidq.html?FBmc0000224) vector, using standard cloning 
techniques. pCaSpeR-AUG-ßgal contains a lacZ-gene which the promoter was 
cloned in front of.  
A PCR reaction was run on DNA isolated from wild type flies using the primers 
2995prom/EcoRI and 2995prom/BamHI, and DyNAzyme™ II DNA polymerase. 
This amplified the region between the ATG of DmG9a, and the ATG of the upstream 
gene CG3038. The product was isolated from agarose gel, and cloned into the 
pCR2.1-TOPO vector, using the TOPO cloning strategy. Both pCR2.1-TOPO-
DmG9aprom and the pCaSpeR-AUG-ßgal vector were cut with the restriction 
enzymes BamHI and EcoRI (Promega), and ligated to each other, using the T4 DNA 
Ligase (Promega), as described in the manufacturer’s protocols. The vector was 
injected into w1118 embryos (Ann Mari Voie) using P-element transformation. These 
transgenic flies were crossed to different balancer stocks in order to map what 
chromosome the insertion had happened. 
2.2.3  Preparation of DNA for injection 
For injection of DNA into Drosophila embryos, 6 µg of cloned plasmid DNA and 2 
µg of helper DNA (∆2-3) were  mixed together with 1/10 volume of 3M NaAc and 
1.5 volumes of 96% ethanol. The DNA was centrifuged (2 min, 13000 rpm) and 
washed in 70% ethanol, before it was air-dried, and dissolved in 20 µl injection 
buffer (5 mM KCl, 0.1 mM phosphate buffer pH 6.8). 
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2.2.4 Generation of DmG9a  mutants by P element excision 
To learn about the in vivo function of the gene DmG9a, deletion mutants were tried 
created by imprecise excision of the P element (P{SUPor-P}) inserted in the 5’-end 
of the gene. The insertion itself has no effect on the transcription of the gene. In order 
to increase the yield of imprecise excision the mus309 trans-heterozygous genotype 
were used. A mus309 heteroallelic combination was used because of the linkage of 
each allele to a recessive lethal mutation(s). 
Single, red eyed, non-TM3, Sb male flies red from the cross (13414/w; 
mus309D2/TM3, Sb X yw; ∆2-3, mus309D3/TM3, Sb) were crossed to FM6,w females. 
190 crosses were set on 18oC, and 70 on 25 oC. Female offspring with white eyes 
were crossed back with male FM6,w. 
2.3 Drosophila methods 
2.3.1 Dissection of ovaries 
Ovaries from virgin, wild type flies were dissected in Ringer’s solution (182 mM 
KCl, 46 mM NaCl, 3 mM CaCl2, 10 mM Tris-HCl). For fixation the ovaries were 
agitated for 10 min in a mixture of 1 volume of fixation buffer (100 mM KH2 
PO4/K2HPO4 (~25:20) pH 6.8, 450 mM KCl, 150 mM NaCl and 20 mM 
MgCl2·6H2O), 4 vol. of dH2O, 1 vol. of 36% formaldehyde, saturated with heptane. 
The ovaries were devitellinized in methanol, and rinsed six times in ethanol, and 
stored at -20oC. 
2.3.2 Collection of embryos 
Embryos from wild type flies were collected on apple juice plates (22.5 g agar, 750 
ml H2O, 25 g sucrose, 250 ml apple juice, 1.5 g nipagin dissolved in 3 ml ethanol) 
after 4 and 18 hours.  
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2.3.3 Fixation and devitellinization of embryos 
Embryos used for immunostaining or whole mount in situ hybridization were 
dechorionated in 50% bleach for 2.5 min., and rinsed in dH2O, alternating with brief 
washes of collection solution (0.04% Triton X-100, 0.7% NaCl). The embryos were 
transferred to a scintillation vial containing fixation buffer (1.3X PBS, 67 mM EGTA 
pH 8.0) together with formaldehyde (4%) and heptane (50%), and shook vigorously 
for 25 min. The lower aqueous phase was removed, and methanol added in order to 
remove the vitelline membrane. After 1 minute of shaking the devitellinized embryos 
would sink to the bottom in the lower methanol phase. These embryos were rinsed 
twice with methanol, and six times with ethanol, and stored at -20oC. 
2.3.4 Whole mount in situ hybridization 
RNA whole mount in situ hybridization was performed essentially as described in 
Tautz and Pfeifle (1989); Jiang et al. (1991), the staining procedure was based on the 
DIG Nucleic Acid Detection Kit (Boehringer Mannheim GmbH).   
Fixated and devitellinized embryos and ovaries were rinsed 4 times in ethanol, then 
rinsed with ethanol:xylene, with increasingly amounts of xylene, before they were 
rocked for 45 minutes in 1:1.25 ethanol:xylene. Ethanol was used for washing 5 
times 3 minutes each, following 2 times 3 minutes rinses in methanol. The embryos 
and ovaries were then washed in PBT (1X PBS, 0.1% Tween 20), and incubated for 8 
minutes in 4 µg Proteinase K in PBT. The digestion was stopped with 2 times rinsing 
followed by washing 4 times 2 minutes in PBT. The samples were refixed for 25 
minutes in PBTF (5% formaldehyde in PBT). PBT was used for washing 5 times 2 
minutes each, then together with hybridization solution (HS - 50% formamide, 5X 
SSC, 100µg/ml sonicated and boiled salmon sperm DNA, 50 µg/ml heparin, 0.1% 
Tween 20) in a 1:1 mixture for 10 minutes. The samples were washed for 2 minutes 
and prehybridized at 55oC for ~1 hour in HS.  0.5 µl of the dig U antisense RNA 
probe was diluted in 50 µl HS, and denatured at 80oC, before added to the ovaries and 
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embryos. Hybridization was performed for 18 hours at 55oC. A sense probe was used 
as negative control. 
The samples were washed first for 1 hour, then 8 times for 15 minutes in HS. PBT 
and HS (1:1) were then used for washing 2 times 15 min, followed by 5 washes for 
10 min in PBT. The anti-digoxygenin-AP antibody (Roche Diagnostics) was diluted 
1:2000 in PBT, and incubated with the samples at 4oC over night (ON).  
Embryos and ovaries were washed 4 times for 15 min in PBT, and then in staining 
buffer (SB -100 mM NaCl, 50 mM MgCl2, 100 mM Tris-HCl pH 9.5, 0.1 % Tween 
20) 2 times for 5 min. NBT/bCIP (Roche Diagnostics) were diluted 1:50 in SB, and 
added to the samples for staining for the amount of time needed to give appropriate 
amount of staining. PBT was used to stop the reaction by rinsing 3 times quickly. The 
samples were then rinsed in PBT with increasingly amounts of ethanol, the samples 
were inverted between each time, before they were rocked in 1:1.25 PBT:ethanol for 
5 min. This was followed by 10 washes for 5-10 min each. Before mounting the 
samples were rinsed in quickly in xylene, before they were coverslipped in Permount 
(Fisher Scientific).  
2.3.5 Probe for whole mount in situ hybridization  
Probe for detection of DmG9a transcript was made by Marianne Stabell (unpublished 
results). 
Probe for detection of the tun transcript was generated by running a PCR reaction 
with one of the positives from the Y2H screen, inserted into the library vector 
pGADT7-Rec as template. IS30084left and IS30084right was use for primers. The 
product was cloned into the vector pCR®II-TOPO by TOPO-cloning. 5 µg of the 
plasmid was cut with the restriction enzyme DdeI at 37oC for ~2 hours.  
The DNA was extracted and diluted in DEPC-H2O. 1 µl of linearized DNA were 
used as substrate for 15 U SP6 RNA polymerase (Promega), 10 µl of the reaction also 
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contained 1X transcription buffer (Promega), 1X DIG-labeled U NTP’s (Roche 
Diagnostics GmbH), 5 mM of DTT (Promega), 48 U RNasin (Promega) and DEPC-
H2O. The reaction mix was incubated for 37oC for 2 hours. dH2O was used to adjust 
the volume of the reaction to 25 µl, and 25 µl 2X carbonate buffer (120 mM Na2CO3, 
80 mM NaHCO3) was added, followed by incubation at 65oC for 10 min. 50 µl 0.2 M 
NaAc (pH 6.0), 10 µl 4 M LiCl, 1 µl tRNA (Sigma-Aldrich) and 300 µl ethanol was 
added, before freezing the reaction for 15 minutes at -20oC. The RNA was 
centrifuged (13000 rpm, 4oC) and washed in 70 % ethanol, before dissolved in 150 µl 
HS. 
2.3.6 Immuno staining  
Antibody staining was performed essentially as described by Robinson and Cooley 
(1997). Fixed and devitellinized embryos and ovaries were rinsed in 50:50 ethanol: 
PBS (130 mM NaCl, 7 mM Na2HPO4, 3 mM NaH2PO4, pH 7.0), three times in PBS 
and washed three times for 10 minutes in PBS. The samples were then incubated for 
10 minutes in PBT (1X PBS, 0.3 % Triton X-100, 0.5 % BSA). α-DmG9a (aa cc + 
1623 -1637) was diluted 1:100 in PBT, and incubated ~18 hours at 4oC. PBT was 
used for rinsing 3 times, then washing 4 times for 15 minutes. Secondary antibody, 
donkey anti-goat conjugated with Cy3 (Jackson Laboratories), diluted 1:200 in PBT, 
and DAPI (1:100) was incubated with the samples for 2 hours at room temperature. 
PBT was used for rinsing and washing as before. Then PBS was used for rinsing 2 
times. The samples was transferred to PBS:glycerol (1:1), and equilibrated for 20 
minutes, before mounted on slide and cover slipped and concealed with nail polish.  
2.3.7 Microscopy  
All microscopy was carried out using a Zeiss Axioplan Imaging2 system equipped 
with Nomarski optics, epifluorescence attachment and cooled LSD imaging facilities. 
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2.4 Yeast two hybrid 
The Yeast Two-Hybrid (Y2H) screen from BD Matchmaker™ Library Construction 
& Screening Kits (BD Biosciences) was used to identify proteins that DmG9a 
interacts with in vivo.  
The baits were cloned using Gateway cloning into the modified vector pGBKT7-
cassette B (Silja S. Amundsen, unpublished results), which was adapted to the 
Gateway® system. Two domains were created for screening; Domain1 and Domain2 
They were created using primers cg2995Y2H3attB1/cg2995Y2H3attB2 and 
cg2995Y2H2attB1/cg2995Y2H3attB2 respectively.  
The LiAc-method was used to the transformation of Y187 yeast cells with the 
pGBKT7-cassette B plasmid. Lithium acetate (LiAc) permeabilized the cell walls and 
DNA was added. Then the cells and DNA was co-precipitated with PEG and 
incubated in 30 min. at 30oC. The cells were briefly heat-shocked, LiAc and PEG 
washed out by DMSO, and then plated on selective medium (SD/-Trp/X-α-Gal, SD/-
His/-Trp/X-α-Gal and SD/-Ade/-Trp/X-α-Gal), to test the DNA-BD fusion for 
transcriptional activation. Inactive bait was indicated by white colonies on SD/-
Trp/X-α-Gal, and by lack of growth on the other plates. 
A colony containing inactive bait was tested for insert by running a PCR-reaction 
with gene specific primers. The same colony was used to make a bait-culture for 
testing the DNA-BD fusion for toxicity. The colony was inoculated in 100 ml SD/-
Trp/Kan (20µl/ml) and grown ON at 30oC with shaking to OD600 of 0.8. The cells 
were resuspended in 5 ml SD/-Trp, and then ready for mating. 
The BD Matchmaker two-hybrid library was screened by yeast mating. The bait 
strain was mated with a previously made library host strain, in 47 ml 2X YPDA/Kan 
(50 µg/ml), by incubation at 30oC ON with shaking at 40 rpm. Then the cells were 
resuspended to a total of 10 ml in 0.5 X YPDA/Kan (50 µg/ml), and plated on 
different dropout media. Mating efficiency was determined by plating on SD/-Leu, 
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SD/-Trp and SD/-Leu/-Trp in different dilutions. The rest was plated on TDO/X-α-
Gal and QDO/X-α-Gal, to selection for yeast diploids expressing interacting proteins. 
TDO stands for triple dropout medium; SD/-His/-Leu/-Trp, and QDO stands for 
quadruple dropout medium; SD/-Ade/-His/-Leu/-Trp, and helps to prevent negative 
positives. 
Positives on the QDO/X-α-Gal plates were re-streaked on SD/-Leu/-Trp/X-α-Gal 3 
times to purify colonies containing only one plasmid. Then the positives were re-
streaked on QDO/X-α-Gal to verify the phenotype. 
After having verified the phenotypes yeast cultures of the positives were made, which 
was further prepped, and used for PCR reactions with the primers 5´AD LD and 
3´AD LD Insert Screening Amplimers BD Biosciences. The PCR products were cut 
with the restriction enzyme AluI to group the positives. Based on this grouping the 
samples were further sequenced to identify the genes (proteins) responsible for the 
interactions. 
2.5 Protein methods 
2.5.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) 
For detection of proteins, SDS-PAGE was used. The detergent sodium dodecyl 
sulfate (SDS) intercalates into hydrophobic parts of the protein and disrupts its 
compact folded structure. At the same time it coats the protein with a layer of 
negative charges which causes them to migrate towards the anode in an electrical 
field, regardless of the net intrinsic charge of the uncomplexed protein.  
The SDS-PAGE gel consists of two layers. First a stacking gel (5 % acrylamide/Bis 
solution, 200 mM Tris-HCl pH 6.8, 0.1 % SDS, 0.1 % APS, 0.1 % N, N, N’, N’-
Tetramethylethylenediamine) on top, and then a separating gel with various 
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concentrations of acrylamide (10/12 % acrylamide/Bis solution, 390 mM Tris-HCl 
pH 8.8, 0.1 % SDS, 0.1 % ammonium persulfate (APS), 0.04 % N, N, N’, N’-
Tetramethylethylenediamine). 5 µl sample buffer were added to 20 µl of  the samples 
(60mM Tris-HCl (pH 6.8), 25 % glycerol, 2 % SDS, 14.4 mM 2-mercaptoethanol, 
0.1 % bromphenol blue), and boiled at 95o C for 5 min, followed by centrifugation 
(13.000) for 5 min. The gel was run in running buffer (25 mM Tris, 192 mM glycine, 
0.1 % SDS) at 19-36 mA for 1 – 1.5 h in the electrophoresis apparatus.  For size 
marker SeeBlue® Plus2 (Invitrogen Life Technologies) was used. 
The gel was stained with Coomassie Brilliant Blue for 30 min, and either destained 
with boiling dH2O for 20 and visualized, or destained (40 % methanol, 10 % acetic 
acid) for 1 – 1.5 h, rinsed twice (7 % methanol, 7 % acetic acid, 1 % glycerol and in 
dH2O), dried and visualized. An untreated gel could also be used further in western 
blotting. 
2.5.2 Recombinant protein expression in bacteria 
In order to express protein in bacterial cells the vector pGEX-GAW-4E cassette B 
(Bitte Stenvik, unpublished results), containing a glutathione S-transferase (GST) tag 
as a fusion to the inserted sequence and a Gateway recombination cassette was used. 
The vector was electro transformed into E. coli BL.21 cells, which have high protein 
expression level. 
To control the size of protein fragments used as bait in the Y2H screen, it was 
expressed and measured using a small scale protocol. Expression of protein was 
induced by adding 0.1 mM of the lactose analog isopropyl ß-D-thiogalactoside 
(IPTG) to cell culture (LB, 100 µg/ml ampicillin or 200 µg/ml carbenicillin), and 
incubating for 30 min at 28o C. The size was measured by running both induced and 
uninduced samples on a standard 10 % SDS-PAGE gel. 
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2.5.3 Protein isolation 
The GST fusion protein produced by the pGEX-GAW-4E cassette B vector can be 
extracted by using Glutathione Sepharose™ 4B (Amersham Biosciences) beads, 
which binds the GST-tag.   
For protein isolation, larger amounts of cells was needed, and expression was induced 
in 250 ml cell culture (0.08 – 0.1 mM IPTG) for 2 h, and controlled by running a 
10% SDS-PAGE gel comparing uninduced and induced samples. The cells were 
sedimented by centrifugation (4500 rpm) for 15 min at 4o C, and resuspended in 20 
ml cold Tris-HCl (50 mM). After a second sedimentation, the cells were resuspended 
in RIPA-buffer (20 mM Tris-HCl pH 7.5, 500 mM NaCl, 5 mM EDTA, 1% 
Nonidet® P 40, 0.5 % sodium deoxycholat, 1 tablet Complete protease inhibitor 
(Roche Diagnostics GmbH) per 50 ml buffer),with 0.025 % lysozyme, and incubated 
at room temperature for 15 min, before frozen down in liquid nitrogen. The cells 
were slowly thawed in running water, before they were disrupted by sonication (3 
times 10 second at 50 % strength). The lysate was centrifuged (18.000 rpm) for 25 
min at 4o C. The supernatant was mixed together with 500 µl 50% solution of 
Glutathione Sepharose™ 4B beads (prepared according to the manufacturer’s 
protocol), and put on a rotating wheel over night at 4oC.  
The beads were sedimented (3000 rpm for 5 min at 4o C) and resuspended in 5 ml 
RIPA-buffer, and stored 10 min at 4oC. This procedure was repeated twice, before 
finally resuspended in 250 µl RIPA-buffer. 50 µl of this mixture as boiled to release 
the protein, and run on a 10 % SDS-PAGE gel for control of the isolation. 
 
2.5.4 In vitro translation 
To translate the interaction partner found by the Y2H screen into protein, the TnT® 
Coupled Reticulocyte Lysate System (Promega) was used, incorporating 35S- Met 
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(Montebello Diagnostics) into the protein. The reaction was set up as recommended 
by the manufacturer. The translation was controlled by running 1 µl on a 10% SDS-
PAGE gel.  
2.5.5 GST-pulldown assay 
The GST-pulldown assay was used to verify interactions discovered by the Y2H-
screen.  
The in vitro translated 35S-labeled protein was first precleared with Glutathione 
Sepharose™ 4B  beads and NTN buffer (20 mMTris-HCl pH 7.5, 100 mM NaCl, 0.5 
% Nonidet® P 40, 1 tablet Complete protease inhibitor per 50 ml buffer) for 45 min 
at 4oC. The supernatant was either saved for use as input, or added to the isolated 
GST-fusion proteins, and incubated for 2 hours at 4o C. After washing with NTN 
buffer, the protein was released from the beads by boiling, and run on a 12 % SDS-
PAGE gel. After staining and destaining, the gel was dried, and signal detected using 
the Typhoon 9400 Variable Mode Imager (Amersham Biosciences). 
2.6 Blotting methods 
2.6.1 Southern blottting 
Southern blotting was performed to detect changes in chromosomal DNA. 
3 µg of genomic DNA from the excision flies were cut with the restriction enzyme 
ClaI at 37oC over night, and ran on a 0.8 % (w/v) agarose gel (3 V/cm) (Sambrook 
and Russell 2001). Afterwards the gel was soaked in denaturing solution (0.5 M 
NaOH, 0.5 M NaCl) 2 times for 20 minutes, rinsed in dH2O, and soaked in 
neutralization (0.5 M Tris-HCl pH 7.5, 1.0 M NaCl. Before blotting the gel was 
rinsed in 10X SSC (1.5 M NaCl, 150 mM Na-citrate).  
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Blotting 
The DNA gel was blotted onto a Hybond-N+ nylon membrane (Amersham 
Biosciences) over night, and baked at 65oC for 15 minutes and UV-crosslinked as 
described by the manufacturer to bind the DNA covalently to the membrane 
(Hoefer® Scientific Instruments). 
Probe labeling 
Probes were made using the rediprime™ II kit (Amersham Biosciences) following 
the manufacturer’s protocol. 25 ng of DNA were used for labeling with 1.5 µl of [32P] 
dCTP (Montebello Diagnostics, 0.56 mBq). The incorporation reaction was incubated 
for 45 minutes at 37o C. 
The probe used for Southern blotting, was generated by using the primers 
2995intron/biotin and 2995intron. DNA from wild type flies was used as template.  
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Hybridization 
Hybridization with radioactive probes was essentially performed as described by 
Galau et al. (1986). All incubation steps, wetting (30 minutes), pre-hybridization (1.5 
hours), hybridization (~18 hours) and washing (1 hour and 30 minutes) was 
performed at 68o C, and all solutions contained 0.7X SSC (105 mM NaCl, 10.5 mM 
Na-citrate).  
For detection, the membrane was wrapped in plastic and exposed for variable 
amounts of time in a cassette containing a Storage Phosphor Screen (Amersham 
Biosciences) and analyzed on a Typhoon 9400 Variable Mode Imager (Amersham 
Biosciences). 
Stripping of membranes 
In order to remove old probe, the membrane was incubated with 1 mM EDTA, pH 
8.0 + 0.1 % SDS until the there was no radioactivity left. 
2.6.2 Western blotting 
Blotting 
Western blotting was used to transfer proteins separated by SDS-PAGE to a solid 
support, to provide a starting point for immunodetection. The protein was transferred 
from the gel onto a PVDF-membrane (Immobilon™-P transfer membranes, 
Millipore), which in advance was given a hydrophilic treatment with methanol, then 
submerged in dH2O before it was put in a blotting buffer. A sandwich complex 
consisting of supporting pads and filter paper (wetted in blotting buffer) was fitted 
into the gel holder and placed in cold blotting buffer (25 mM Tris, 192 mM glycine, 
20 % methanol) and run at 100 V for 1 h, in the presence of a cooling element and a 
stirring magnet at 4oC. 
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Immunodetection 
The membrane produced by Western blotting was used for detection of specific 
proteins by antibodies. The blocking solution used consisted of PBS with 2.5% Skim-
milk and 0.1% Tween 20. The membrane was placed in a suitable dish and incubated 
on a shaker in four steps. In the first step the membrane was incubated with 15 ml 
blocking buffer and the primary antibody (diluted 100x) for 90 min. This step was 
followed by washing; 5 x 5 min in 15 ml blocking buffer. In the third step 15 ml 
blocking buffer and 1.5 µl anti-rabbit horseradish peroxidase was incubated for 60 
min. This was followed by a new series of washing. For detection, a 
chemiluminescent kit (SuperSignal Chemiluminescent Substrate; Pierce) was used, 
and the work performed in a dark room. An equal volume of the two substrates in the 
kit was mixed as described by the manufacturer. The membrane was incubated in this 
solution for 2 min before it was removed and the membrane was wrapped in plastic 
foil. Then an X-ray film (Kodak) was placed against the blot and exposed for various 
time depending on the amount of signal expected. The film was then developed in an 
Optimax Film Processor (Protec). 
2.7 RNA/DNA methods 
2.7.1 RNA isolation 
Total RNA was isolated from 10-50 mg wild type adult flies, embryos and ovaries, 
using the Trizol® reagent (Invitrogen Life Technologies) according to the 
manufacturer’s instructions, and quantified on a GeneQuant spectrophotometer 
(Pharmacia). 
  51
  
2.7.2 RT-PCR 
cDNA was generated using SuperScript™III First-strand Synthesis System for RT-
PCR (Invitrogen Life Technologies). The reactions were in general set up as 
described by the manufacturer. 5 µg of isolated RNA was incubated at 65o C for 5 
min together with 0.78 mM dNTP’s and 385 ng/µl pd(N)6 (Amersham Biosciences) 
in a total reaction volume of 13 µl. After a brief centrifugation the following reagents 
was added; 4 µl 5X first-strand buffer, 1 µl 0.1 M DTT and 1 µl SuperScript™III (50 
units). The samples were then incubated at 50oC for 60 min before the enzyme was 
inactivated at 70oC for 15 min. The cDNA could now be used as template for 
amplification by PCR; 1 or 2 µl of the first-strand reactions were used. The PCR 
reactions were set up with the DyNAzyme™ II DNA Polymerase (Finnzymes) using 
standard conditions as described in chapter 2.8.1. 
2.7.3 DNA from single flies 
A single fly was homogenized with a pipette tip containing 50 µl Squishing buffer 
(10 Mm Tris-HCl pH 8.2, 1 mM EDTA, 25 mM NaCl, 200 µg/ml Proteinase K) for 
10-20 seconds. The buffer was then emptied in the tube, which was incubated at 
room temperature for 30 minutes. The Proteinase K was inactivated by incubation for 
1-2 minutes at 95oC. The DNA was stored at -20oC. 
2.7.4 CTAB-protocol 
0.1-0.5 g flies were incubated with 2X CTAB (2% CTAB, 1 M Tris-HCl pH8, 0.5 M 
EDTA, 5M M NaCl diluted in 2-mercaptoethanol) and 100 µg Proteinase K, at 60oC 
for 1 hour. The DNA was extracted in 1X phenol:chloroform (1:1) and 1X 
chloroform, the samples were inverted on wheel for 15 min and centrifuged (13.000 
rpm) for 20 min each time. The top phase was transferred to a new tube, and 96% 
ethanol was added, the sample was then incubated at RT for 10 min, before 
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centrifugation (13.000 rpm) for 5 min. 70% ethanol was used for washing the pellet, 
which was dried and dissolved in 50 µl dH2O. 
2.8 Cloning 
2.8.1 PCR 
Standard PCR reactions were set up with DyNAzyme™ II DNA Polymerase 
(Finnzymes) or PuRe Taq Ready-To-Go™ PCR beads (Amersham Biosciences). For 
longer amplifications BD Advantage™ 2 Polymerase (BD Biosciences Clontech) or 
Platinum® Taq High Fidelity (Invitrogen Life Technologies) was used. In the 
reactions where high-fidelity amplification was required, Pfu DNA Polymerase 
(Fermentas Life Sciences) was preferred, because of its 3'=>5' exonuclease 
(proofreading) activity.  
200 µM dNTP’s was already included in PuRe Taq Ready-To-Go™ PCR beads; in 
all other reactions 160 µM was used. Primers (Invitrogen Life Technologies) were 
always diluted to a final concentration of 160 nM each. Annealing temperature varied 
according to the melting temperature (Tm) of the primers in the reaction, usually 
between 50-60o C. For reactions with BD Advantage™ 2 Polymerase, both annealing 
and extension was performed at 68o C. Extension time varied with the length of the 
expected PCR product, and number of cycles was normally 25, but was sometimes 
increased to 30 or 35, to obtain more product. All other parameters followed the 
manufacturers’ recommendations. The specific primers used can be found in 
Appendix 1. 
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2.8.2 Agarose gel electrophoresis 
DNA were size fractioned on 1.0-1.2 % agarose gel’s (SeaKem® LE agarose, 
Cambrex Biosciences, 1 x TAE buffer (40 mM Tris-acetate, 1 mM EDTA), 0.6 µg/ml 
ethidium bromide). The markers GeneRuler™ 1kb DNA ladder (Fermentas Life 
Sciences) and φχ174 Hae III (Promega) were used for comparison. The gel was run at 
60-100 V in 1 x TAE buffer for 30 to 60 min.  
For DNA purification from gel the Wizard® Plus Minipreps DNA purification 
system (Promega) was used, following the supplier’s protocol. 
2.8.3 Ligations, restriction digests and transformations 
Ligations and digests were set up as specified by the manufacturers, using T4-ligase 
from Promega and restriction enzymes from Fermentas, New England Biolabs or 
Promega. 
Plasmids were transformed into either chemically Library Efficiency® DH5α 
Competent Cells (Invitrogen Life Technologies), or electrically competent BL21 E. 
coli cells, using standard techniques (Sambrook and Russell 2001). Bacteria was 
grown on  standard LA-agar plates or in LA medium (Sambrook and Russell 2001), 
containing different antibiotics depending on what resistance gene the vector 
contained.  
2.8.4 DNA purification 
Plasmid DNA was purified from bacteria using either Wizard® Plus SV Minipreps 
(Promega), Quantum Prep® Plasmid Miniprep Kit (Bio-Rad Laboratories) or 
Qiagen® Plasmid Maxi Kit (Qiagen), following protocol from supplier.  
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2.8.5 DNA quantification 
DNA was quantified using the Hoefer DyNAQuant 200 fluorometer (Hoefer® 
Scientific Instruments) using the fluorescent dye Hoechst 33258, according to 
manufacturer instructions. 
2.8.6 Sequencing 
Sequencing were performed at the Department of Molecular Biosciences (IMBV) 
sequencing facility, which uses MegaBACETM 1000 and DYEnamic ET Dye 
Terminator Cycle Sequencing Kit (Amersham Biosciences)  
2.8.7 Gateway cloning 
The Gateway® cloning system (Invitrogen Life Technologies) was used to generate 
vectors used in various assays. This system is based on the site-specific 
recombination properties of the bacteriophage λ, which are conservative and highly 
specific, when it is integrated into the bacterial genome in the switch from lysogenic 
to lytic life cycle. The recombination involves two major components; the DNA 
recombination sequences (att-sites), and the proteins that mediate the recombination 
reaction. The att-sites serves as binding sites for recombination proteins (Weisberg et 
al. 1983). 
The fragment to be cloned was amplified by PCR with primers containing two 
different att sequences, attB1 and attB2, to maintain orientation of the fragment. In 
the BP reaction the PCR-product was recombined into entry vector by, which further 
was cloned into a destination vector by the LR reaction. All reactions were set up as 
described in the manufacturer’s protocol. 
  55
  
2.8.8 TOPO cloning 
Some DNA polymerases add a deoxyadenosine (A) to the 3’ end of the PCR 
products. These ends align with the overhanging 3’-thymidine (T) on the TOPO-
vectors. A Topoisomerase I, which is normally found in the Vaccinia virus, is 
covalently bound to this vector, and uses these overhanging ends to ligate the PCR 
product into the vector. The reactions were set up as described by the manufacturer 
(Invitrogen Life Technologies). 
2.9 Bioinformatics 
Database searches for protein sequences were performed using BLASTP whereas for 
nucleotides the BLASTN database was used (http://www.ncbi.nlm.nih.gov/BLAST/). 
For identification of protein domains the SMART database was used 
(http://smart.embl-heidelberg.de/, (Schultz et al. 1998)). Nuclear localization signals 
were identified by running a search in the PredictNLS online database 
(http://cubic.bioc.columbia.edu/cgi/var/nair/resonline.pl). Multiple alignments of 
protein sequences were done with the ClustalX program (http://bips.u-
strasbg.fr/fr/Documentation/ClustalX/(Thompson et al. 1997)) and manually adjusted 
with the GeneDoc program (http://www.psc.edu/biomed/genedoc/). For DNA 
sequence analysis and primer analysis the Vector NTI v 9.0.0 (Informax).  
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3. Results 
3.1 DmG9a is a putative histone methyl-transferase  
In order to identify genes involved in epigenetic regulation of transcription, the 
“signature motif” of lysine-specific HKMTs, the SET domain, was used as bait in a 
BLASTP search. The search was performed using the SET domain of the well 
characterized Drosophila Su(var)3-9 gene, and identified the annotated CG2995 as a 
putative HKMT gene in Drosophila melanogaster (Marianne Stabell, unpublished 
results). Based on the homology of the SET domain, the proteins in this family is 
divided into four families, SU(VAR)3-9, E(Z), ASH1, and TRITHORAX (Jenuwein 
et al. 1998), and CG2995 belongs to the first family. By using the SMART database 
(Schultz et al. 1998), one cysteine rich preSET domain, 6 ankyrin repeats and a coiled 
coil domain were identified, in addition to the conserved SET domain (Fig. 3.1A). A 
BLASTP search using the whole sequence of CG2995 protein showed that it is 
homologous to mammalian G9a with 30% amino acid identity and 47% amino acid 
similarity. G9a is a characterized HKMT , and shares the same modular design as 
CG2995, with a preSET domain, 6 ankyrin repeats, a coiled coil domain and, in 
addition, a cysteine rich postSET domain (Fig.3.1B; (Milner and Campbell 1993). 
Therefore, CG2995 will go under the name Drosophila melanogaster G9a (DmG9a). 
Alignment of DmG9a, the Drosophila SU(VAR)3-9 and Mus musculus G9a showed 
that DmG9a has the four sequence motifs thought to involved in the methylation 
process (Cheng et al. 2005) in addition to the conserved postSET domain. (Fig. 
3.1C). DmG9a located on the X-chromosome and has been mapped to cytological 
band 1A1 (Fig. 3.1D) (The FlyBase Consortium, 2003). Based on the fact that 
DmG9a shows homology to the mammalian SET domain encoding gene G9a, which 
has been shown to have methyl-transferase activity, it was chosen for further studies 
in Drosophila melanogaster. 
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Figure 3.1: Drosophila DmG9a: Identified domains, alignment with homologues and genomic location. 
(A) Modular design of DmG9a based on domains identified by the SMART database. Numbers below indicate 
amino acids. (B) Modular design of MmG9a. (C) Alignment of DmG9a (CG2995), Drosophila SU(VAR)3-9 
(AE003708) and MmG9a (AAC84164). The degree of conservation is distinguished at four levels (100, 80 and 
60%, and not conserved), where 100% has the darkest shade of gray. The upper and lower case letters in the 
consensus line indicate 100 and 80% conservation within all groups, respectively. Only 100%, 80% and not 
conserved was identified. Numbers in the consensus line represent conserved similarity groups as defined by 
the Blosum 62 scoring table. Lines directly below the consensus sequence indicate the four conserved motifs 
revealed by (Cheng et al. 2005). (D) DmG9a (CG2995) highlighted in red, is located on the X-chromosome, 
cytological band 1A1. The figure shows other genes located close to DmG9a, but there are no other genes 
predicted to overlap with it (adapted from FlyBase; The FlyBase Consortium, 2003).  
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3.2 Investigating the in vivo function of DmG9a 
An effective way of dissecting the function of a gene is to create a knock-out mutant 
which may indicate which processes it is involved in, and whether it is essential or 
redundant. In Drosophila, one popular strategy is to use P-elements inserted in the 
coding or regulatory region of the gene in question. For DmG9a, stock #13414 from 
the Berkeley Drosophila Genome Project was available at the Bloomington 
Drosophila stock center (Spradling et al. 1999). This stock has the element P{SUPor-
P} inserted into the 5'-UTR. This insertion, however, do not cause any phenotypic 
effects, and the flies have normal expression of DmG9a. This was shown by Southern 
hybridization and RT-PCR (Marianne Stabell, unpublished results). By mobilizing 
the P-element to transpose imprecisely, we hoped to create deficiencies in the 
DmG9a gene and thus a reduction of DmG9a transcript. To mobilize the P{SUPor-
P}element the transposase ∆2-3 was crossed into the #13414 line, together with the 
two mus309 alleles in trans, which increases the rate of imprecise excision. 260 
crosses were set up and the progeny was screened for white eyes. 19 lines with 
possible excisions were found. These were further investigated by Southern and PCR 
to map the excision, but did not give any usable results.  
The assay was based on the belief that the P-element had the eye-color marker w+ 
(mini-white), which gives red eyes, and identifies an insertion against a background 
of non-transformed flies with white eyes. It was later found that it was instead the 
body-color marker y1, which was used on this specific P-element. This would explain 
the difficulties of mapping the excision direction and size. Since the assay was 
performed on the wrong basis, it would be necessary to perform new crosses in order 
to obtain new stocks that could be used for screening of mutants. Due to lack of time 
this was not possible. 
Another approach to investigate in vivo function is to express the gene of interest 
ectopically. There are a large number of P-element vectors for Drosophila based on 
the GAL4/UAS system where one could clone the gene of interest behind a UAS 
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promoter, which can be activated by Gal4. One of these vectors is pPWF, which is 
also adapted to the Gateway-system. DmG9a was successfully cloned into pPWF and 
injected into Drosophila embryos. Three lines of transgenic flies were obtained and 
crossed with flies which had Gal4 ectopically expressed. The progeny did not show 
any phenotypic changes compared to wild type flies. Virgin female flies from the F1 
progeny were crossed to wild type males in order to investigate if ectopic expression 
of DmG9a affected oogenesis. However, this cross did not give any phenotypic 
abnormalities. 
Admittedly, over-expression of DmG9a protein was not confirmed, so it is unknown 
whether the lack of phenotype was due to redundancy of the DmG9a protein itself, or 
that the over-expression vector failed to be expressed at all.  
3.3 DmG9a mRNA is present in embryos and ovaries of 
Drosophila  
Whole mount in situ hybridization was performed on Drosophila embryos and 
ovaries in order to detect the transcript of DmG9a.  
At stage 1-4 of embryo development a series of 13 mitotic nuclear divisions, 
unaccompanied by cytokinesis, takes place to produce a multinucleated single cell 
embryo, the syncytial blastoderm. Moderate levels of DmG9a mRNA were uniformly 
spread along embryos at this stage (Fig. 3.2A). This was also seen in the blastoderm 
of stage 5 embryos (Fig. 3.2B), which is when cellularization starts and a 
multicellular embryo is formed. These results indicate that the gene is maternally 
supplied, because there is little or no transcription before stage 5 in Drosophila 
embryos. During gastrulation DmG9a transcript was seen in the area where ectoderm 
and mesoderm develops (Figs. 3.2C and D). Mesoderm is the precursor cells of the 
fat body, muscles, heart and the somatic portion of the gonads, while ectoderm gives 
rise to the epidermis, tracheal tree, nervous system and the fore- and hindgut and their 
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annexes. The negative control with DmG9a sense probe did not show any staining 
that would interfere with the interpretation of the results (Fig. 3.2E). 
Whole mount in situ hybridization using an antisense probe specific for DmG9a 
indicated that the gene is maternally deposited in the oocyte, and is expressed in the 
progenitor cells of various tissues in the developing embryo. 
 
Figure 3.2: Whole mount in situ hybridization of Drosophila embryos against DmG9a. (A) Stage 4 
embryo, a syncytial blastoderm. (B) Stage 5 embryo; cellularization starts. (C) Stage 8 embryo during 
gastrulation. (D) A stage 5 embryo hybridized with a DmG9a sense probe for negative control.  (E) Showing a 
stage 9 embryo stained with antibody against the gene twist, which is expressed within the entire mesoderm 
Picture adapted from FlyMove (Weigmann et al. 2003) 
Nurse cells synthesize and transport the cytoplasmic components that support the 
development of the oocyte and, later, the embryo. During the stages 1-9 of oogenesis, 
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the nurse cells produce moderate amounts of transcripts, which are transported to the 
oocyte. At stage 9 through 10A a dramatic increase in transcription starts, which is 
seen by the increase in oocyte size. DmG9a transcript was clearly visible in the 
oocytes from stage 9 (Fig. 3.3A), and weakly in nurse cells. At stage 10 the transcript 
was strongly expressed both the cytoplasm of nurse cells and in the oocyte (Figs. 
3.3B and C). Towards the final steps of oogenesis there is no or very little DmG9a 
transcript in the oocyte, whereas it still remains in the nurse cells (Fig. 3.3D). In the 
mature oocyte there is no detectable DmG9a transcript (Fig. 3.3E). 
 
Figure 3.3: Whole mount in situ hybridization of DmG9a in ovaries. (A) Stages 1-9. (B) Stage 10A. (C) 
Stage 10 B. A microfilament-dependent contraction of the nurse cells begins now. (D) Stage 11. Nurse cells 
deposit their cytoplasmic constituents into the oocyte before the nurse cells degenerate during stage 12. (E) 
Stage 14. Egg ready for fertilization. 
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3.4 DmG9a protein is present in nuclei of embryos, and 
both nuclei and cytoplasm of ovaries 
DmG9a encodes a putative histone methyl-transferase, and the protein was therefore 
expected to be located in the nucleus. In line with this notion a putative nuclear 
localization signal, PKRSKRR, was identified when the DmG9a protein sequence was 
submitted into the PredictNLS online database 
(http://cubic.bioc.columbia.edu/cgi/var/nair/resonline.pl).  
As Figure 3.4 shows the nuclear localization was also confirmed by antibody staining 
against DmG9a in Drosophila embryos. DmG9a is associated with nuclei in the 
syncytial blastoderm at stage 4 (Fig. 3.4A). At stage 5 DmG9a is also detected in the 
uncellularized nuclei in the center of the embryo, in addition to the blastoderm cells 
around the perimeter of the entire egg (Fig. 3.4C). After gastrulation (stage 9) 
DmG9a protein could be seen in the ectoderm (Fig. 3.4E), which gives rise to 
epidermis and nervous system, etc. 
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Figure 3.4: DmG9a expression during Drosophila embryo development. (A and B) Stage 4 embryo (A) 
antibody against DmG9a and (B) DAPI staining. (C and D) Stage 5 embryo, (C) antibody staining, (D) 
Nomarski (E and F) Stage 9 embryo, (E) antibody staining, (F) DAPI staining.    
As Figure 3.5 shows, DmG9a protein also is present in ovaries of Drosophila 
melanogaster. It is detected in follicle cells from the early stages of oogenesis, but 
towards the later stages the protein level seems to be reduced (Figs. 3.5A-D). The 
somatic follicle cells participate in signaling which determines the oocyte, and later 
the polarity of the embryo. In addition, polarized follicle cells secrete the proteins 
making up the oocyte vitelline membrane and eggshell late in oogenesis.  
DmG9a seems also to be present in nurse cell nuclei in the early stages of oogenesis, 
with the strongest signal around stage 10A (Fig. 3.5E). At the beginning of stage 11 
the protein is shifted from the nuclei to the cytoplasm (Fig. 3.5G). This happens after 
a dramatic rearrangement of filamentous actin to form actin-bundles, approximately 
at the same time as the cell nuclear envelope becomes permeabilized. This means that 
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DmG9a is transported into the cytoplasm during initiation of apoptosis. DmG9a 
levels are reduced towards stage 14, along with the degeneration of nurse cells (Fig. 
3.5I). 
 
Figure 3.5: Immunostaining against DmG9a in ovaries. (A-B) Stage 1-8 egg-chambers. (C-D) Stage 9 egg-
chamber. (E-F) Stage 10A egg-chamber. (G-H) Stage 12 egg-chamber. (I-J) Stage 11 egg-chamber. (A-I) α-
DmG9a. (B-J) DAPI. 
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3.5 DmG9a interacts with the LIM-domains of Tungus 
In this study the Y2H assay was used to analyze the protein-protein interaction profile 
of the DmG9a protein. Because of its relatively long ORF, which could be difficult to 
express in yeast, it was divided into smaller fragments, each of which was screened 
separately. To reduce the risk for the domains to not fold properly, whole modules 
was used for bait. 
First, Domain 1 (Fig. 3.6 A), was used as bait. This fragment, from amino acids 1046 
to 1335 contained the six ankyrin repeats (ANK), a ubiquitous motif which has been 
showed to function in protein-protein interactions (Bork 1993). The sequence was 
successfully cloned into the vector pGBKT7-cassette B and transformed into Y187 
(MATα) yeast cells. This bait was found to autoactivate in these cells, which was 
seen by blue colonies appearing on SD/-His/-Trp and SD/-Ade/-Trp with x-α-
galactocidase, before mating. The same was reported to happen with the DmG9a 
homologue HsG9a in a high-throughput yeast two hybrid screen performed by 
another group (Lehner et al. 2004). This is an indication of the domains’ activity as 
transcriptional activator. The baits were expressed as fusions to the GAL4 DNA 
binding domain, and activated the transcription of the lacZ-gene, without help of the 
GAL4 activation domain. Acidic amphipathic domains are often responsible for 
unwanted transcriptional activation, and the pI of Domain 1 of DmG9a was 
calculated to 4.58. This bait, with its low pI was not suited for further research by the 
Y2H-system.  
To circumvent the problem above, the bait was expanded and the more upstream 
region of the gene was included; resulting in Domain 2. (Fig. 3.6A). This bait had a 
pI of 7.90 and did not autoactivate. The bait strain was mated with the yeast AH109 
strain, containing a library of adult Drosophila melanogaster cDNA. The mating 
efficiency was calculated to 1.32 %, which is lower than the protocol 
recommendations, but the mating reactions still gave positive interactions. Thirteen 
colonies were found to grow on QDO plates, which indicated that the bait had 
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successfully been activated by an interaction partner fused to the Gal4 activation 
domain. PCR reactions were run, using the primers 5´AD LD and 3´AD LD, on all 13 
interaction partners. The products were cut with the frequent cutting restriction 
enzyme AluI (Fig. 3.6B), and this showed that all but one (#6) of the positives 
seemed to be the same gene. Samples 1, 6, 10, 12 and 13 were sequenced, and 
BLAST searches with these sequences against the Drosophila melanogaster genome 
were performed. All 5 samples gave the same result; the gene picked up was 
CG30084, also called tungus (tun). This gene is cytologically mapped to band 52C4-
7 on chromosome arm 2R, and is annotated as alternatively spliced in FlyBase 
(http://flybase.bio.indiana.edu/) with 4 transcripts, PA-PD (Fig. 3.6C); this is not 
molecularly verified, however. By comparing the sequencing results with the 
annotated sequence it was shown that it either was transcript PA or PD that interacted 
with DmG9a. All 5 Y2H-positives also aligned with the same area in TUN, starting 
approximately 15 aa upstream of the 3 LIM-domains (Linl-1, Isl-1 and Mec-3)  at the 
end of the protein, which was identified by using the SMART database on TUN-PD 
(Fig. 3.6D). All 4 transcripts of tun have the same modular design, the difference 
between them lies in the distance form the first LIM-domain to the cluster of 3 LIM-
domains. The LIM domains are tandem zinc-finger structures that function as 
modular protein-binding interfaces (reviewed in (Kadrmas and Beckerle 2004). This 
strongly suggests that DmG9a interacts with TUN in the LIM-domains, possibly 
through the ANK-repeats, which are known to be involved in protein-protein 
interactions. In addition to the three LIM-domains at the C-terminal end, one PDZ-
domain (PSD-95, Dlg and ZO-1), an α-Actinin binding ZASP-like Motif (ZM) and a 
fourth LIM-domain was identified in the N-terminal end of TUN. 
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Figure 3.6: Y2h-screen.  (A) The two different domains of DmG9a used for the Y2H- screen indicated by 
lines below the gene. (B) Restriction cutting with AluI of the 13 positives found in the screen. (C) The 
Drosophila gene tungus (CG30084), highlighted in red, is located on chromosome arm 2R, cytological band 
52C4--7. The gene is annotated with 4 alternative transcripts (adapted from FlyBase (The FlyBase Consortium, 
2003)). (D) Overview over the domains of Tungus identified with the SMART database. 
 
On order to verify the interaction further a GST-pulldown experiment was performed. 
The bait was expressed in bacteria and isolated while the interactant TUN was in 
vitro translated (Fig. 3.7). However, the experimental conditions prevented the assay 
to be completed, and further adjustments were required to optimize the reactions. 
This was not done due to lack of time. 
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Figure 3.7: Expression in BL21-cells of DmG9a-Domain2 and in vitro translation of TUN. 
3.6 Tungus contains an α-Actinin binding domain 
The 26 aa long ZM-motif identified in Tungus was named after the human protein 
ZASP (Z-band alternatively spliced PDZ-motif protein), which is a protein associated 
with the Z-line in muscles (Faulkner et al. 1999). This is a specialized structure 
connecting adjacent sarcomeres in muscle cells. ZASP has a homologue in mouse 
called Cypher; sequence and structure comparison suggests that TUN is a homologue 
to these two proteins (Figs. 3.8 and 3.7). ZASP/Cypher also has a PDZ-domain in the 
N-terminal end and three LIM-domains in the C-terminal. PDZ domain is a widely 
expressed protein-protein interaction domain, with a subgroup of PDZ-LIM proteins 
(Harris and Lim 2001). PDZ-LIM proteins can be divided in two subclasses; they 
either contain one or three LIM-domains in the C-terminal end. ZASP and Cypher 
belongs to the second class, while the proteins ALP (Actinin-associated LIM protein) 
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and CLP36 (C-terminal LIM domain protein) belongs to the first (Fig. 3.8). All these 
proteins have been detected in the muscle Z-line in mammals and shown to interact 
with α-Actinin (Xia et al. 1997; Faulkner et al. 1999; Zhou et al. 1999; Bauer et al. 
2000).                                 
 
Figure 3.8: PDZ-LIM containing proteins. Modular design of the Drosophila protein TUN (splice variant 
PD, NP_788358), Homo sapiens ZASP (CAB46728), ALP (AAB96665), CLP36 (CAC32846) and Mus 
musculus Cypher (splice variant 1c, AAD42950). The proteins are drawn to scale, and the length is indicated to 
the right. The square shows the different domains identified by the SMART database. 
The ZM-motifs and PDZ-domains of the previously identified PDZ-LIM proteins 
were aligned against TUN, and Figure 3.9 shows that TUN is conserved in both 
domains. This indicates that is a putative α-Actinin binding protein.  
 
Figure 3.9: Alignment of ZM-motifs and PDZ-domains. Alignment of ZM-motifs (A) and of PDZ-domains 
(B) of the genes in Figure 6.  
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3.7 DmG9a is abundantly transcribed in ovaries, whereas 
tun is detected in all developmental stages  
The expression of DmG9a and tun was analyzed by reverse transcriptase PCR (RT-
PCR). As shown in Fig. 3.10, DmG9a transcript was found in all stages of embryos 
and larvae. 0-3h embryos corresponds to approximately stages 1-7 set by (Campos-
Ortega and Hartstein 1985), 3-6 to stages 8-10, 6-9h to stages 11-12 and 9-24h to 
stages 13-17.  In pupae the amount or transcript is very low, while in adult flies with 
their gonads removed there appears to be no DmG9a transcript. The highest amount 
of transcript is found in ovaries while in testis there is also a moderate amount. tun 
seems to be evenly distributed in all the samples. Rp49 was used as loading control. 
 
Figure 3.10: RT-PCR expression analysis.  Agarose gels stained with ethidium bromide showing cDNA 
fragments of DmG9a, tun and rp49 (positive control) amplified by RT-PCR using gene specific primers. 
Tissues used are depicted on top. Female and male is adult flies with their sex organs removed. 
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3.8 tun is expressed in Drosophila ovaries and embryos 
Whole mount in situ hybridization towards tun transcript showed that the gene is 
transcribed in the oocyte of stage 9 egg chambers (Fig. 3.11A), at the same time as 
DmG9a transcript is first detected. But while the transcript of DmG9a spreads to 
nurse cells from early stage 10, the tun transcript stays in the oocyte from stage 10A 
through stage 12 (Figs. 3.11B-D). In the following stages, the transcript is no longer 
detectable (Fig. 3.11E). In stage 5 embryos tun transcript is evenly distributed. 
 
Figure 3.11: Whole mount in situ hybridization of tun. (A) Stage 1-9 egg-chambers. (B) Stage 10A egg-
chamber. (C) Stage 11 egg-chamber. (D) Stage 12 egg-chamber. (E) Stage 14, mature egg. (F) Stage 5 embryo. 
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4. Discussion 
The evolutionarily conserved SET-domain proteins in eukaryotes have been shown to 
function as site-specific histone lysine methyl-transferases (HKMTs), and play an 
important role in regulating chromatin-mediated gene transcriptional activation and 
silencing. As an approach to gain further insights into the mechanisms of epigenetic 
gene regulation, a putative histone methyl-transferase was identified and 
characterized in Drosophila melanogaster.   
4.1 DmG9a belongs to the Su(var)3-9 family of SET-
domain genes 
Drosophila melanogaster G9a (DmG9a) was identified based on the SET-domain of 
the well characterized Drosophila histone methyl-transferase Su(var)3-9, and was 
named after its homologue in mammals, G9a, in this study. DmG9a, Su(var)3-9 and 
mammalian G9a all belongs to the Su(var)3-9 family of SET-domain genes classified 
by (Jenuwein et al. 1998). Many of the proteins in this family have been shown to 
methylate histone H3 lysine (K) 9 (Lachner et al. 2003), including Su(var)3-9 
(Czermin et al. 2001; Schotta et al. 2002), suggesting that DmG9a also methylates 
H3-K9. However, this remains to be shown. 
Mammalian G9a is able to add methyl groups to H3-K27 as well as to H3-K9 
(Tachibana et al. 2001). The euchromatic H3-K9 specific activity regulated by mouse 
G9a (MmG9a) has been shown to be essential for early embryogenesis and is 
involved in the transcriptional repression of developmental genes (Tachibana et al. 
2002).  
SU(VAR)3-9 is associated with heterochromatin, it interacts with and creates binding 
sites for HP1 (Jacobs et al. 2001; Schotta et al. 2002), and has been shown to be the 
main, but not the only H3-K9 HKMT in Drosophila (Schotta et al. 2002). In flies, as 
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well as in other species, it has been observed that some HKMTs have the same target 
lysine, which raises the issue of redundancy of their functions. This might explain the 
lack of phenotypic abnormalities in the over-expression lines of DmG9a. However, 
this could also be caused by failure in expressing the vector injected into Drosophila 
lines.  
In addition to having the four conserved sequence motifs in its SET-domain, DmG9a 
also possesses the flanking cysteine rich sequences which have previously been 
shown to be important for HKMT activity (Rea et al. 2000; Zhang et al. 2002). Thus, 
DmG9a shares all the features of a SET-domain gene, validating its possible function 
as an HKMT. 
4.2 DmG9a is a maternal gene required during early 
embryogenesis 
As MmG9a had been shown to be embryonic lethal and essential for early 
development (Tachibana et al. 2002), it was natural to investigate expression pattern 
of DmG9a in Drosophila embryos. Whole mount in situ hybridization showed that 
transcript is uniformly present in both stage 4 and 5 embryos. At stage 8, during 
gastrulation, transcript is seen in the area where mesoderm and ectoderm develops. 
However, it is difficult to specifically decide which of those cell layers it is 
transcribed in due to indistinct staining. The presence of DmG9a transcript in early 
embryos was also confirmed in a high-throughput RNA in situ protocol used to 
determine patterns of expression for various genes in Drosophila embryonic 
development (Tomancak et al. 2002). Here, however, staining was only observed 
from stage 1 through stage 3 embryos. Our RT-PCR results clearly showed, however, 
that DmG9a transcript is present during all stages of embryonic development; this 
result was also supported by seeing presence of protein at stage 8 (Fig. 3.4E).  
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The fact that DmG9a transcript is present in early embryos, before the maternal to 
zygotic transition (MZT), shows that the gene is expressed during oogenesis and 
deposited into the oocyte before fertilization. There is little or no transcription in 
early Drosophila embryos, further supporting the maternal origin of DmG9a.  
The localization of DmG9a protein in embryos was also investigated. Early embryos 
showed that DmG9a accumulates in the nuclei in the syncytial blastoderm. During 
the cellularization process, which starts around stage 5, DmG9a remains associated 
with the nuclei which are transported towards the perimeter of the embryo, in 
addition to remain in the uncellularized nuclei in the center. This confirmed that 
DmG9a is located in the nucleus, which is as expected of an HKMT associated with 
chromatin. Also the identification of a NLS supports this notion. Later in 
development, at stage 9, DmG9a becomes associated with ectoderm. This primordial 
cell layer of the germ band is divided in two clearly defined regions, one that gives 
rice to the neuroblasts and the ventrolateral epidermis. From the other ectodermal 
region, the dorsal epidermis and the tracheal placodes develop. The staining of 
DmG9a shows that it most likely is associated with the first region, also called the 
neurogenic region. 
It has been shown that maintenance of CpG methylation at the Prader-Willi 
Syndrome Imprinting Center in mouse embryonic stem cells might be dependent on 
G9a, indicating that the protein has a possible role in imprinting in mice (Xin et al. 
2003). As DmG9a also seems to be involved in embryonic development suggests that 
also DmG9a may be involved in regulation of DNA methylation. In Drosophila the 
overall methylation level of DNA is rather low, with the highest levels found in early 
embryos (Lyko et al. 2000), which coincides with the expression of DmG9a. The 
function of DNA methylation in Drosophila, however, is not well characterized 
(Field et al. 2004), and its existence is controversial. What possible epigenetic 
processes DmG9a might be involved in sustains further investigation. 
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4.3  DmG9a is synthesized in nurse cells of Drosophila 
ovaries 
Having shown that DmG9a is a maternal gene, and that it is expressed in ovaries, it 
was obvious to investigate the expression pattern in this organ. Transcript is first 
detected at stage 9, strongly in the oocyte and weakly in nurse cells. In the following 
stages the amount of transcript seems to be reduced in the oocyte while it increases in 
nurse cells. One possible interpretation of this observation is that DmG9a is deposited 
into the oocyte mainly at stage 9, and that further increase in oocyte size reduces the 
overall concentration of transcript here. The increased level of transcript in nurse 
cells might then reflect a separate function in these cells, indicating that DmG9a is 
involved in regulation of transcription in both oogenesis and early embryonic 
development. During the final stage of development is not possible to detect DmG9a 
transcript in the mature egg, in contradiction to what is expected for a maternal gene. 
One possible explanation is that the probe was unable to penetrate the chorion 
surrounding the egg. This tough extracellular layer is synthesized during late 
oogenesis (Margaritis et al. 1980), and is removed from embryos when they are 
prepared for in situ hybridization or immunostaining. However, ovaries are not 
subject to dechorination as the treatment probably is too harsh and would ruin early 
egg chambers.   
DmG9a protein is detected in egg chambers during early stages of oogenesis, from 
stage 1 to 8, clearly in follicle cell nuclei and weakly in nurse cell nuclei. However, 
transcript is not visible in these stages; this could be explained by its low 
concentration or that the fluorescent antibody is more readily detected than the anti-
DIG antibody.  Another, less likely possibility is that the protein is synthesized in the 
germarium, and follows the nuclei throughout oogenesis.   
The presence of protein in the nuclei of nurse cells and follicle cells supports the 
observation from the whole mount in situ hybridization assay that DmG9a probably 
is involved in transcriptional regulation of genes involved in oogenesis, in addition to 
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the early embryonic development in Drosophila. Surprisingly, DmG9a transcript was 
also found in testis, indicating a role during spermatogenesis. This might reflect a 
possible role for DmG9a in gonad development or in the development of germline 
cells. 
The transcript of DmG9a is first detected in the oocyte at stage 9, but the protein is 
not detected in the oocyte. Transcriptional products from the oocyte nucleus 
contribute little to the RNA and protein that will sustain early embryonic 
development (Mahajan-Miklos and Cooley 1994), so the transcript seen in the oocyte 
is probably synthesized and transported from the nurse cells.  
Around stage 11 DmG9a is shifted from being in the nuclei of nurse cells to 
accumulate in the cytoplasm. This happens simultaneously as a modified form of 
apoptosis starts (Buszczak and Cooley 2000), and a rapid transport phase where the 
remaining cytoplasmic contents of the nurse cells is transferred to the oocyte as a 
result of a myosin-based contraction. Instead of being transferred to the oocyte, 
however, DmG9a seems to remain in the nurse cells when they contract. The protein 
might be degraded at this stage, as the presence of the caspase DREDD is reported 
from stage 10 (Chen et al. 1998); DREDD is a protein that normally accumulates in 
cells specified to enter apoptosis.   
4.4 DmG9a interacts with the maternal product of tungus 
As the entire DmG9a protein was considered too big to serve as bait in the Y2H-
screen, it was therefore divided into smaller fragments. The ankyrin repeats identified 
in both DmG9a and MmG9a (Milner and Campbell 1993), are known to function in 
protein-protein interactions (Bork 1993), and were selected to serve as bait for the 
Y2H screen. As observed for human G9a and Drosophila Su(var)3-9 (Schotta et al. 
2002; Lehner et al. 2004), also this part of DmG9a auto activated in the Y2H-system. 
This was possible to circumvent by expanding the fragment upstream to give a higher 
  77
  
pI. Only one putative interaction partner, Tungus, was found using this part of 
DmG9a as bait. The interaction was also confirmed by performing a small scale 
mating in yeast. There are a couple of explanations for the single hit; the screen was 
performed using a cDNA library of adult flies, while a more common approach is to 
screen a library from embryos. Also, only a part of the protein was used in the screen, 
and other interaction partners might bind to other parts of DmG9a.  
tun seems also to be a maternal gene as the transcript is detected in early Drosophila 
embryos. In egg chambers the transcript is visualized in the oocyte from around stage 
9, the same stage as DmG9a. Here it remains until at least stage 11. tun is not 
detected in the mature egg, probably for the same reason as for DmG9a.  
4.5 Tungus is a putative α-Actinin binding protein 
By analyzing the sequence of Tun, four LIM domains, one PDZ domain and one ZM 
domain were found. The LIM domain is thought to function as protein interaction 
modules, and the three in the C-terminal end of TUN probably interacts with the 
ANK-repeats in DmG9a. Also, PDZ domains function in protein-protein interactions 
and one subgroup of PDZ proteins have both a PDZ and one or more LIM domains 
(Harris and Lim 2001), and are regarded as mediators between cytoskeletal structures 
and signaling cascades. Some of the proteins in this subgroup also have the ZASP 
motif (ZM), including the homologues to TUN; ZASP, Zypher, ALP and CLP36. All 
of these proteins have been shown to interact with α-Actinin in mammals (Xia et al. 
1997; Faulkner et al. 1999; Zhou et al. 1999; Bauer et al. 2000), and it is therefore 
reasonable to predict that also TUN can bind the same protein. The single copy 
version of α-actinin in Drosophila is alternatively spliced to generate three isoforms 
that are expressed in larval muscle, adult muscle and non-muscle cells (Roulier et al. 
1992), and it is closely related to the vertebrate muscle α-Actinins showing nearly 70 
% amino acid identity (Fyrberg et al. 1990). In skeletal and cardiac muscles, α-
Actinin is a major component of the Z-disc, where it cross-links actin filaments from 
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adjacent sarcomeres (Clark et al. 2002). In non-muscle cells it has various roles in the 
cell, being an adhesion linked, filament-binding scaffold molecule (Otey and Carpen 
2004). In Drosophila α-Actinin is ubiquitously expressed in wild type embryos 
(Wahlstrom et al. 2004). RT-PCR showed an equal amount of transcript in all tissues 
investigated, as one would expect from actin, which often is used as a positive control 
due to its even distribution in all tissues. The possible interaction between TUN and 
α-Actinin has been verified by the group of Mateos and Baylies (2005), who showed 
that the two proteins colocalize in the Z-disk, that they share some mutant phenotypes 
and that TUN show muscle expression in late embryo stages (Mateos and Baylies 
2005). As TUN probably binds α-Actinin, it is not expected to be present in the 
nucleus. However, an intron protein GFP trap strategy used to predict nuclear 
localization of various Drosophila proteins (Morin et al. 2001) shows that TUN is 
expressed in the nuclei of both nurse cells and follicle cells 
(http://flytrap.med.yale.edu/, Fig. 4.1). 
 
Figure 4.1: TUN expression in ovaries, pictures obtained from FlyTrap 
(http://flytrap.med.yale.edu/)
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4.6 TUN might function as a signal for DmG9a  
In Drosophila ovaries non-muscle α-Actinin is localized in the nurse cell subcortical 
cytoskeleton, actin cables and ring canals (Wahlstrom et al. 2004), which means that 
it does not co localize with tun. This indicates that TUN is a protein with multiple 
functions, however, what function it has in ovaries is unknown. The closest 
characterized homologue to tun is the C. elegans protein EAT-1, which has four 
isoforms (McKeown and Beckerle 2003). One of these isoforms shows nuclear 
localization, and it is postulated that the protein plays a direct role in signaling 
(McKeown and Beckerle 2003). Among the multiple roles of non-muscle α-Actinin 
that has been shown, one is to serve as a scaffold to connect the cytoskeleton to 
diverse signaling pathways. Taken together, this allows us to speculate that TUN is 
functioning as a signal that activates DmG9a during Drosophila oogenesis, as the 
colocalization shown for TUN and DmG9a strengthens the notion that they may 
interact. This is an interesting observation that requires further investigation. 
In early stage embryos both DmG9a, tun and predominantly non-muscle α-Actinin is 
expressed (Wahlstrom et al. 2004). Cellularization of the Drosophila embryo occurs 
at stage 5, when plasma membrane invaginates to form cleavage furrows between the 
cortical nuclei, a process known to be associated with actin and myosin II-based 
contractile apparatus (Warn and Robert-Nicoud 1990; Young et al. 1991). This 
indicates that there is a connection between DmG9a and TUN also at this stage, and 
that TUN might function as a signal for DmG9a, which again may regulate genes 
involved in the cellularization process.  
Non-muscle α-Actinin is mainly expressed in young embryos, while muscle α-
Actinin is abundant in larvae, pupae and adults (Wahlstrom et al. 2004). TUN show 
expression both in early and in late embryo stages (Mateos and Baylies 2005), which 
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means that the protein probably associates with both non-muscle and muscle α-
actinin. 
To investigate further the interaction between DmG9a and TUN it will be necessary 
to separate between the different splice variants of tun. DmG9a interacted with TUN-
PA or Tun-PD, while none of the in situ or RT-PCR results for TUN referred to here 
has been specific for different splice variants. They might be differently expressed, as 
has been shown for eat-1 (McKeown and Beckerle 2003). 
Another possible function for TUN has also been investigated by Dubnau et al. 
(2003). This group has shown that a tun mutant shows a defective one-day memory, 
and that it is expressed in mushroom bodies, which are symmetrically paired 
neuropils in the insect brain that are of critical importance for associative olfactory 
learning and memory. An interesting feature of DmG9a is that it seems to be 
expressed in the neurogenic region, the progenitor cells of nervous system. This 
suggests that DmG9a might function as transcriptional regulator in the early 
development of the nervous system. 
4.7 A possible link between the nucleus and actin 
Surprisingly, our results indicate that a putative SET-domain protein possibly 
interacts with TUN, which is associated with actin. However, another SET-domain 
protein CG12196 has also showed interaction with TUN (Marianne Stabell, 
unpublished results). In addition, CG12196 showed interaction with Spire, an actin 
nucleation factor (Quinlan et al. 2005). Another SET-domain containing protein in 
mammals, EZH2, has recently been reported as an essential regulator of cellular 
signaling via ligand-induced actin polymerization in various cell types (Su et al. 
2005). Actin, however, has also been proved important in the nucleus as a component 
of the RNA polymerase II-based transcription machinery (Hofmann et al. 2004). All 
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these observations support our results, and reveal an interesting link between nuclear 
transcription factors and actin that needs to be further investigated.    
4.8  Future work    
Although several observations indicate that DmG9a is a functional HKMT, this has 
yet to be verified by in vitro experiments such as the histone methyltransferase assay 
described in (Rea et al. 2000). This is, however, an ongoing project in the group, and 
is essential not only for the demonstration of enzymatic activity, but also in order to 
elucidate the specificity of the protein. Over the last several years different antibodies 
has been generated that is specific for different histone residues and methylation 
states. Knowing what exact residue the DmG9a methylates would give a strong 
indication for what function it has in vivo. Another method for investigation of the 
function of a gene is through “knock-out” or “knock-down”. The first alternative 
requires creation of a mutant strain, as was tried during this project. An alternative is 
(Schotta et al. 2002) to perform a “knock-down” experiment using RNAi. In addition 
to turning off the gene in all cells it would be possible to investigate what happens if 
the amount of protein is reduced in specific tissues or at specific times. This is 
especially important in cases where the mutation is recessive lethal of heterozygous 
lethal.  
If a mutant line for DmG9a were to be created it would be interesting to investigate 
the methylation pattern of H3-K9 in early Drosophila embryos of DmG9a; Su(var)3-
9 double mutant flies. In single mutant Su(var)3-9 flies there is a small amount of 
methylated H3-K9 in embryos (Schotta et al. 2002), and DmG9a could be responsible 
for this methylation. 
During this study a promoter analysis assay was started, in order to study in what 
tissues DmG9a is transcribed. Transgenic stocks expressing lacZ in the same patterns 
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as DmG9a were obtained, however, due to lack of time the expression pattern was 
not investigated, and still remains to be done. 
In the Y2H-screen TUN was identified as an interaction partner for DmG9a. 
Although several observations support this relationship, it has not been verified in 
vitro. This is, however, important to do in order to confirm the interaction. GST-
pulldown is one method for this purpose that is established in our laboratory; 
alternatively it is possible to perform a coimmunoprecipitation. 
If the interaction was verified a further examination of the expression pattern of tun 
could give supplementary insight into the function of DmG9a. Antibodies are under 
production, and these will help investigate expression pattern for the TUN protein. It 
would also be possible to study whether DmG9a and TUN colocalize, and in that 
case; where. 
Hopefully the results found from these investigations, and further studies concerning 
DmG9a will contribute to new knowledge and better understanding of epigenetic 
regulation of transcription. 
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Appendix 1 
Experiment Comment 
Primer 
name Sequence Tm (oC) 
Control of insert DmG9a    2995leftRNAi 5´- TGTCGCACTTCTCGTTCATC – 3´ 50.9 
Control of insert DmG9a    2995seq3R 5´- ACCATCATTGTGCAGCGTAG – 3´ 51.0 
In situ probe/RT-PCR tun   IS30084left 5´ - GAAAGGGCCGTAAGTCAGTT - 3´ 50.2 
In situ probe/RT-PCR tun   IS30084right 5´ - ATGGAAGTGTTTGCCAATGG – 3´ 52.3 
Loading control RT-PCR   rp49L 5´- TGACCATCCGCCCAGCATAC - 3´ 57.9 
Loading control RT-PCR   rp49R 5´- TCTCGCCGCAGTAAACGC - 3´ 54.8 
Overexpression   2995cDNAattB1 5´- GGGGACAAGTTTGTACAAAAAAGCAGGCTGCAAGATGACGGACTTTGTT - 3´ 79.0 
"   cg2995Y2H4attB2 5´ - GGGGACCACTTTGTACAAGAAAGCTGGGTACGCGTGTCCAATTTTCTCCGT – 3´ 81.8 
Probe Southern   2995intron/biotin 5´- AAGCACAAGGACAAGGAGGA - 3´ 51.2 
"   2995intron 5´- CGCATTTTGTATGTGGTTCG - 3´ 51.6 
Promoter analysis   2995prom/EcoRI 5´ – GGCGAATTCTTTTCTTACATTCTACGTGG – 3´ 42.3 
"   2995prom/BamHI 5´ – CAAGGATCCCTTGCCTTAATTGTCACTAT - 3´ 41.4 
RT-PCR DmG9a   2995right(RNAi) 5´ – ACTATCCAGGCAGGAGCAGA - 3´ 51.3 
"   2995left(RNAi) 5´ – GATGAACGAGAAGTGCGACA - 3´ 50.9 
Screening of Y2H positives 
and In vitro translation of tun 
for GST-pulldown 
  
5´AD LD-Insert 
Screening 
Amplimer 
5´- CTATTCGATGATGAAGATACCCCACCAAACCC – 3´ 67.0 
"   
5´AD LD-Insert 
Screening 
Amplimer 
5´- GTGAACTTGCGGGGTTTTTCAGTATCTACGATT - 3´ 66.1 
Y2H-bait Domain2 cg2995Y2H2attB1 5´- GGGGACAAGTTTGTACAAAAAAGCAGGCTACGAACTGCGCTGTGAGTTCGAA – 3´ 81.4 
" Domain1 and Domain2 cg2995Y2H3attB2 5´- GGGGACCACTTTGTACAAGAAAGCTGGGTAAACCACAAAGGTACGGAGGCC – 3´ 80.9 
" Domain1  cg2995Y2H3attB1 5´- GGGGACAAGTTTGTACAAAAAAGCAGGCTCATATCCCGCGGGGTAAACTCTG – 3´ 81.3 
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